AIM
AIM ImmunoTech
34 hedge funds and large institutions have $3.36M invested in AIM ImmunoTech in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$17K | |
| 2 | +$5.8K | |
| 3 | +$2.63K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$525 |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$286 |
Top Sellers
| 1 | -$117K | |
| 2 | -$24K | |
| 3 | -$8.51K | |
| 4 |
Jane Street
New York
|
-$8K |
| 5 |
BlackRock
New York
|
-$1.86K |